Proshare Ltd has invested 0% in Insulet Corporation (NASDAQ:PODD).
Jan 1, 2019 | investtribune.comIn addition to its continuing digital and social marketing, Insulet has launched new direct-to-consumer TV advertising to raise awareness of Omnipod 5, the first tubeless AID system in the United States.
Jan 1, 2022 | thehealthco.info“Mddionline is proud to partner with Insulet, combining its industry-leading Dexcom G6 CGM technology with their tubeless, wearable insulin delivery system, to improve clinical outcomes and reduce the burden of glucose management for people with diabetes.”
Sep 21, 2022 | mddionline.com“Asianhhm is proud to partner with Insulet, combining its industry-leading Dexcom G6 CGM technology with their tubeless, wearable insulin delivery system, to improve clinical outcomes and reduce the burden of glucose management for people with diabetes.”
Sep 19, 2022 | asianhhm.comIn June 2020, Roche filed a lawsuit against Insulet ( PODD ) alleging patent infringement in connection with the company’s Omnipod Insulin Management System.
Jul 11, 2022 | seekingalpha.comInsulet ( NASDAQ: PODD ) said its Chief Operating Officer and Executive Vice President Charles Alpuche would retire from his position, effective December 31.
Dec 14, 2022 | seekingalpha.comIn April 2022, Insulet launched New Omnipod 5 System Data for type 1 and type 2 diabetes.
Dec 30, 2022 | onlinebeststor.com